Svolgo attività di ricerca clinica nell’ambito delle malattie neurodegenerative e dei disturbi cognitivi, con particolare attenzione alla malattia di Alzheimer, ai biomarcatori (EEG, risonanza magnetica, biomarcatori plasmatici e liquorali) e alla gestione dei pazienti in trattamento con anticorpi monoclonali anti-amiloide.

Sono autore e co-autore di numerose pubblicazioni su riviste internazionali peer-reviewed. Di seguito una selezione rappresentativa.

• Cecchetti G, Agosta F, Rugarli G, et al. Diagnostic accuracy of automated Lumipulse plasma pTau-217 in Alzheimer's disease: a real-world study. Journal of Neurology, 2024.

• Filippi M, Cecchetti G, Spinelli EG, et al. Amyloid-Related Imaging Abnormalities and β-Amyloid-Targeting Antibodies: A Systematic Review. JAMA Neurology, 2022.

• Agosta F, Cecchetti G, Spinelli EG, et al. MRI protocols and sequences for amyloid-related imaging abnormalities monitoring in Alzheimer's disease patients treated with monoclonal antibodies. Current Opinion in Neurology, 2025.

• Cecchetti G, Agosta F, Basaia S, et al. Resting-state electroencephalographic biomarkers of Alzheimer's disease. NeuroImage: Clinical, 2021.

• Filippi M, Cecchetti G, Agosta F. MRI in the new era of antiamyloid monoclonal antibodies for the treatment of Alzheimer's disease. Current Opinion in Neurology, 2023.

• Cecchetti G, Basaia S, Canu E, et al. EEG correlates in the three variants of primary progressive aphasia. Neurology, 2024.

• Canu E, Rugarli G, Basaia S, Cecchetti G, et al. Real-world application of the AT(N) classification and disease-modifying treatment eligibility in a hospital-based cohort. Journal of Neurology, 2024.

• Cecchetti G, Agosta F, Canu E, et al. Analysis of individual alpha frequency in a large cohort from a tertiary memory center. European Journal of Neurology, 2024.

• Zavarella M, Cecchetti G, Rugarli G, et al. Favorable long-term cognitive outcomes following recurrent ARIA linked to amyloid-lowering therapies: two cases. Journal of Neurology, 2025.

• Filippi M, Cecchetti G, Cagnin A, et al. Redefinition of dementia care in Italy in the era of amyloid-lowering agents: expert opinion and practical guideline. Journal of Neurology, 2023.